Targeting Oncogenes into a Defined Subset of Mammary Cells Demonstrates That the Initiating Oncogenic Mutation Defines the Resulting Tumor Phenotype

Holloway, Kimberly R.; Sinha, Vidya C.; Bu, Wen; Toneff, Michael; Dong, Jie; Peng, Yi; Li, Yi

doi:10.7150/ijbs.12947



Theranostics

International Journal of Medical Sciences

Nanotheranostics

Journal of Cancer

Journal of Genomics

Global reach, higher impact

Full Text | PDF

Int J Biol Sci 2016; 12(4):381-388. doi:10.7150/ijbs.12947 This issue Cite

Research Paper

Targeting Oncogenes into a Defined Subset of Mammary Cells Demonstrates That the Initiating Oncogenic Mutation Defines the Resulting Tumor Phenotype

Kimberly R. Holloway^1*, Vidya C. Sinha^1,2*, Wen Bu^1,2, Michael Toneff², Jie Dong², Yi Peng^3,4, Yi Li^1,2✉

1. Lester & Sue Smith Breast Center, Baylor College of Medicine, Houston, TX, USA;
2. Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX, USA.
3. National Center for International Research of Biological Targeting Diagnosis and Therapy, Guangxi Medical University, Nanning, Guangxi 530021, China;
4. Guangxi Key Laboratory of Biological Targeting Diagnosis and Therapy Research, Guangxi Medical University, Nanning, Guangxi 530021, China.
* These two authors contributed equally to this work.

Citation:

Holloway KR, Sinha VC, Bu W, Toneff M, Dong J, Peng Y, Li Y. Targeting Oncogenes into a Defined Subset of Mammary Cells Demonstrates That the Initiating Oncogenic Mutation Defines the Resulting Tumor Phenotype. Int J Biol Sci 2016; 12(4):381-388. doi:10.7150/ijbs.12947. https://www.ijbs.com/v12p0381.htm

Other styles

Abstract

Breast cancers exhibit high intertumoral heterogeneity in genetic alterations as well as histopathological and other phenotypic characteristics. The contribution of the initiating oncogenic mutation to tumor phenotype remains controversial, largely due to the technical difficulties in delivering genetic alterations into well-defined subsets of mammary epithelial cells. To examine how different initiating oncogenes drive tumor phenotype, we somatically delivered two oncogenes (ErbB2, PyMT) into a narrow and distinct subset of the mouse mammary epithelium defined by the expression of the progenitor marker keratin 6a (Krt6a), and compared the phenotypes of the resulting mammary tumors. While PyMT-induced tumors were well-differentiated and displayed glandular and papillary features, ErbB2-induced tumors were poorly differentiated and exhibited epithelial-to-mesenchymal transition as well as β-catenin activation. These in vivo data demonstrate that the initiating oncogene plays a key role in driving mammary tumor phenotype.

Keywords: Keratin 6a, PyMT, ErbB2, Breast Cancer, RCAS, tva

Citation styles

APA

Holloway, K.R., Sinha, V.C., Bu, W., Toneff, M., Dong, J., Peng, Y., Li, Y. (2016). Targeting Oncogenes into a Defined Subset of Mammary Cells Demonstrates That the Initiating Oncogenic Mutation Defines the Resulting Tumor Phenotype. International Journal of Biological Sciences, 12(4), 381-388. https://doi.org/10.7150/ijbs.12947.

ACS

Holloway, K.R.; Sinha, V.C.; Bu, W.; Toneff, M.; Dong, J.; Peng, Y.; Li, Y. Targeting Oncogenes into a Defined Subset of Mammary Cells Demonstrates That the Initiating Oncogenic Mutation Defines the Resulting Tumor Phenotype. Int. J. Biol. Sci. 2016, 12 (4), 381-388. DOI: 10.7150/ijbs.12947.

NLM

CSE

Holloway KR, Sinha VC, Bu W, Toneff M, Dong J, Peng Y, Li Y. 2016. Targeting Oncogenes into a Defined Subset of Mammary Cells Demonstrates That the Initiating Oncogenic Mutation Defines the Resulting Tumor Phenotype. Int J Biol Sci. 12(4):381-388.

This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) License. See http://ivyspring.com/terms for full terms and conditions.